Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05963854 · ClinicalTrials.gov registry record
Food Survey, Curbside, Remote APPs SC
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 232
- Enrollment target
NCT05963854: Completed study, sponsored by Pennington Biomedical Research Center.
NCT05963854 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 232 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05963854 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 232 participants
- Enrollment target
Study Summary
The proposed research will create accurate and standardized household FW measurement methodologies that foster serial and longitudinal assessments as well as confident and convenient one-time measurement by stakeholders. The investigators will have participants simutaneously deploy (1) retrospective surveys (2) curbside audits.
Primary Outcome
Weight
Interventions
- OTHER Survey Curbside
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2023-07-25 |
| Est. Completion | 2024-11-19 |
What the finished NCT05963854 record still lists
NCT05963854 is an observational study that tracks outcomes without assigning an intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey Curbside is the first listed.
NCT05963854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05963854 about?
NCT05963854 is a clinical study titled "Food Survey, Curbside, Remote APPs SC". The proposed research will create accurate and standardized household FW measurement methodologies that foster serial and longitudinal assessments as well as confident and convenient one-time measurement by stakeholders. The investigators will have participants simutaneously deploy (1) retrospective...
What is the current status of trial NCT05963854?
This trial is currently completed. The enrollment target is 232 participants. The study started on 2023-07-25. Estimated completion is 2024-11-19.
What interventions are being tested in trial NCT05963854?
The interventions under investigation include: Survey Curbside (OTHER).
Who is sponsoring clinical trial NCT05963854?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI